Eplerenone for the Treatment of Central Serous Chorioretinopathy

Summary

To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .

Timeline

Start

2013-10

Primary completion

2015-03

Completion

2015-05

Publications

• Lange CA, Qureshi R, Pauleikhoff L. Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.

Drugs

Indications